Nektar Therapeutics (NKTR)
(Delayed Data from NSDQ)
$1.30 USD
+0.03 (2.36%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.30 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 33% (82 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 3.50 | 1.58 | 9.99 |
Current Quarter Estimate | -0.23 | -1.06 | 61.00 |
Year Ago Quarter Estimate | -0.19 | -0.06 | 54.84 |
Next Quarter Estimate | -0.22 | -1.85 | 63.00 |
Next Year Estimate | -0.69 | 12.67 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 41.38 | 20.70 | 15.67 |
Next Year | 18.82 | 16.20 | 11.34 |
Last 5 Years | -227.60 | 7.80 | 8.10 |
Next 5 Years | NA | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -1.82 |
Price/Book (MRQ) | 2.93 | 1.59 |
Price/Cash Flow (MRFY) | NA | 9.47 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -190.09% | -61.35% |
Return on Equity (TTM) | -133.64% | -58.93% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.